medigraphic.com
ISSN 1561-3127 (Digital)
ISSN 0864-3466 (Impreso)

2016, Número 3

<< Anterior Siguiente >>

Revista Cubana de Salud Pública 2016; 42 (3)


El rol de farmacia en la vigilancia de la salud en Costa Rica

Jiménez HL

Idioma: Español
Referencias bibliográficas: 61
Paginas: 418-431
Archivo PDF: 96.49 Kb.


RESUMEN

Introducción: La vigilancia de la salud es una función esencial de la salud pública en la que deben participar diferentes actores. La normativa vigente para Costa Rica, delimita el quehacer de algunos actores y de otros no, como es el caso de farmacia.
Objetivo: Describir aspectos relacionados con las acciones de los especialistas en farmacia en el proceso de vigilancia de la salud en el contexto costarricense.
Métodos: Investigación cualitativa realizada entre agosto y octubre del 2014. Se visitaron 22 áreas de salud en la zona urbana y 5 en la rural, se entrevistaron de forma voluntaria y confidencial a informantes claves, 22 de farmacia, 2 de medicina, 1 de enfermería, 1 psicología y 1 de trabajo social; todos miembros de las comisiones locales de vigilancia epidemiológica.
Resultados: El accionar de los especialistas en farmacia está centrado principalmente en las labores específicas tradicionales que se realizan en un establecimiento farmacéutico, funciones relacionadas con la gestión de los medicamentos. Se ejecutan menos labores orientadas hacia lo externo en el escenario poblacional, rol que se encuentra limitado debido a necesidades y dificultades administrativas.
Conclusiones: Los especialistas en farmacia tienen potencial y oportunidades para realizar actividades de vigilancia de la salud, la hacen en parte pero con poco protagonismo porque su función continúa centrada en el medicamento sin proyección hacia otros escenarios de la atención primaria en la salud. Están ausentes otras actividades que podrían contribuir a lograr mejores condiciones de bienestar en las diversas poblaciones.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Gorgas M, Pàez F, Camós J, de Puig E, Jolonch P, Homs E, et al. Programa de atención farmacéutica integrada en pacientes con enfermedades crónicas. Farmacia Hospit. 2012 [citado 18 Feb 2016];36(4):229-39. Disponible en: http://www.sciendirect.com/science/article/pii/S1130634311001954

  2. Bardet J, Vo T, Bedouch P, Allenet B. Physicians and community pharmacists collaboration in primary care: A review of specific models. Res Social Administrative Pharm. 2015 [citado 17 Feb 2016];11(5):602-22. Disponible en: http://www.sciendirect.com/science/article/pii/S1551741114004094

  3. Panamerican Health Organization, World Health Organization (PAHO/WHO). Renewing Primary Health Care in the Americas. Washington, D. C.: PAHO/WHO; 2007 [cited 2015 Dic 2]. Available at: http://apps.who.int/medicinedocs/documents/s19055en/s19055en.pdf

  4. Organización Panamericana de la Salud. El papel del farmacéutico en el sistema de atención de salud. Informe de la reunión de la OMS, del 31 de agosto al 3 de septiembre. Tokio, Japón: Representación OMS; 1993 [citado 3 Dic 2015]. Disponible en: http://www.ops.org.bo/textocompleto/ime9848.pdf

  5. Eisenhower C. Impact of Pharmacist-Conducted Medication Reconciliation at Discharge on Readmissions of Elderly Patients with COPD. Ann Pharmacother. 2014 [cited 2016 Feb 18];48(2):203-8. Available at: http://aop.sagepub.com/content/48/2/203.full.pdf+html

  6. Santamaría G, Gómez L. Tendencias internacionales en la educación farmacéutica. Enlace Quím. 2010 [citado 1 Dic 2015];1(1):7-12. Disponible en: www.uaemex.mx/enlacequimico/docs/NumAnt/EQa1n12010.pdf

  7. Organización Panamericana de la Salud. Servicios farmacéuticos basados en la atención primaria de salud. Documento de posición de la OPS/OMS. Washington, D. C.: OPS; 2013 [citado 2 Dic 2015]. Disponible en: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=215 82&Itemid=

  8. Organización Panamericana de la Salud/Organización Mundial de la Salud. La Salud Pública en las Américas. Funciones esenciales. Washington, D: C.: OPS/OMS; 2001 [citado Dic 4 2015]. Disponible en: http://www1.paho.org/hq/dmdocuments/2010/FESP_Salud_Publica_en_las_Americ as.pdf

  9. Ministerio de salud de Costa Rica MINSA. Reglamento de Vigilancia de la Salud Nº 37306-S. Gaceta 203. Alcance 160. Costa Rica: MINSA; 2012 [citado 23 Nov 2014]. Disponible en: http://www.imprentanacional.go.cr/pub/2012/10/ /ALCA160_22_10_2012.p

  10. Andrus M, Stevenson T. Three-year review of pharmacy students' interventions and activities in an outpatient teaching family medicine center. Curr Pharmacy Teach Learn. 2015 [cited 2016 Feb 18 ];7(2):192-8. Available at: http://www.sciencedirect.com/science/article/pii/S1877129714001774

  11. Palombi L, Kading M, Hayes C. The public health pharmacist and the role of the pharmacy curriculum: A call to action. Curr Pharmacy Teach Learn. 2013 [cited 2016 Feb 17];5(5):477-82. Available at: http://www.sciencedirect.com/science/article/pii/S1877129713000932

  12. Vieira P, Mitsue A, Cordoni L. Caracterización de los servicios farmacéuticos de atención primaria del Sistema Único de Salud en Londrina, Paraná, Brasil. Rev Panam Salud Publica/Pan Am J Public Health. 2009 [citado 2 Dic 2015];25(3):254- 59. Disponible en: http://iris.paho.org/xmlui/handle/123456789/9843?localeattribute= es

  13. Bodenheimer T, Pham H. Primary Care: Current Problems and Proposed Solutions. Health Aff. 2010 [cited 2015 Dic 1];29(5):799-805. Available at: http://content.healthaffairs.org/content/29/5/799.full

  14. Ruales M. Elementos para la elaboración de un programa de vigilancia epidemiológica en atención farmacéutica. Rev Centro Estudios Salud. 2002 [citado 29 Nov 2015];1(3):60-4. Disponible en: http://revistasalud.udenar.edu.co/?p=75

  15. Haas-Gehres A, Sebastian S, Lamberjack K. Impact of pharmacist integration in a pediatric primary care clinic on vaccination errors: A retrospective review. J Am Pharm Assoc. 2014 [cited 2016 Feb 18];54(4):415-8. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217275/

  16. Gaitán H, Gómez P, Escalava J. Actitudes del personal en la vigilancia de eventos adversos intrahospitalarios en Colombia. Rev salud pública. 2008 [citado 28 Nov 2015];11 (5):745-53. Disponible en: http://www.scielosp.org/pdf/rsap/v11n5/v11n5a07.pdf

  17. Mossialos E, Naci H, Courtin E. Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence? Health Pol. 2013 [cited 2016 Feb 17];111(2):135-48. Available at: http://www.sciencedirect.com/science/article/pii/S0168851013001000

  18. Olsson E, Ingman P, Ahmed B, Kälvemark S. Pharmacist-patient communication in Swedish community pharmacies. Pharmacist-patient communicat Swedish comm pharmacies. 2014 [cited 2016 Feb 18];10(1):149-155. Available at: http://www.sciencedirect.com/science/article/pii/S1551741113000430

  19. Dobson R, Taylor J, CHenry J, Lachaine J, Zello G, Keegan D, et al. Taking the lead: Community pharmacists' perception of their role potential within the primary care team. Res Social Administrative Phar. 2009 [cited 2015 Dic 6];5:327-36. Available at: http://www.sciencedirect.com/.../pii/S1551741108001137

  20. Poulose S, Cheriyan E, Cheriyan R, Weeratunga D, Adham M. Pharmacistadministered influenza vaccine in a community pharmacy: A patient experience survey. Can Pharmacists J. 2015 [cited 2016 Feb 18];148(2):64-7. Available at: http://cph.sagepub.com/content/148/2/64.full.pdf+html

  21. Tucker R, Duffy J. The Role of Community Pharmacists in the Management of Skin Problems. J Pharmaceutical Care Health Sys. 2014 [cited 2016 Feb 18]. Available at: http://www.omicsgroup.org/journals/the-role-of-communitypharmacists- in-the-management-of-skin-problems-JPCHS-1-105.php?aid=25890

  22. Márquez S. Promoción de la salud y prevención en tiempos de crisis: el rol del sector sanitario. Informe SESPAS 2014. Gacet Sanit. 2014 [citado 17 Feb 2016];28:116-23. Disponible en: http://ac.els-cdn.com/S0213911114000466/1- s2.0-S0213911114000466-main.pdf?_tid=1940a34e-d66f-11e5- 8a7100000aab0f6b&acdnat=1455821015_13248baba997e09e59306927f604e122

  23. Jorgenson D, Dalton D, Farrell B, Tsuyuki R, Dolovich L. Guidelines for Pharmacists Integrating into Primary Care Teams. Can Pharmacists J. 2013 [cited 2015 Dic 8];146(6): 342-52. Available at: https://www.usask.ca/pharmacynutrition/ research/Spotlight%20on%20Research/derek-jorgenson.php

  24. Azhar S, Azmi M, Izham M, Ahmad M, Masood I, Akmal A. The role of pharmacists in developing countries: the current scenario in Pakistan. Human Res Health. 2009 [cited 2015 Nov 30];7:54. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714831/

  25. Smith M, Bates D, Bodenheimer T, Cleary P. Why Pharmacists Belong In The Medical Home? Health Aff. 2010 [cited 2015 Dic 8];29(5):906-13. Available at: http://www.content.healthaffairs.org/content/29/5/906.abstract

  26. Mak V, Clark A, March G, Gilbert A. The Australian pharmacist workforce: employment status, practice profile and job satisfaction. Australian Health Rev. 2013 [cited 2015 Dic 7];37:127-30. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23158000

  27. Rey A, Acosta N. El enfoque de competencias para los equipos de Atención Primaria en Salud. Una revisión de literatura. Rev Gerenc Polit Salud. 2013 [citado 30 Nov 2015];12(25):28-39. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657

  28. Saramunee K, Krska J, Mackridge A, Richards J, Suttajit S, Phillips P. How to enhance public health service utilization in community pharmacy? General public and health providers' perspectives. Res Social Administrative Phar. 2014 [cited 2015 Dic 1];10:272-84. Available at: http://www.sciencedirect.com/science/article/pii/S1551741112000745

  29. Mourelle J, Cruz M, Broche L, García A, López Á. Importancia de los comités farmacoterapéuticos en la toma de decisiones en salud. Rev INFODIR. 2014 [citado 17 Feb 2016];17. Disponible en: http://revinfodir.sld.cu/index.php/infodir/article/viewFile/23/49

  30. Nissen L. Current status of pharmacist influences on prescribing of medicines. Am J Health-Syst Pharm. 2009 [cited 2015 Nov 30];66(Suppl 3):S29-34. Available at: http://www.ajhp.org/content/66/5_Supplement_3/s29.full.pdf+html

  31. Pradeep G. The Evolving Role of the Community Pharmacist in Chronic Disease Management - A Literature Review. Acad Med Singapore. 2010 [cited 2015 Dic 8];39:861-7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21165527

  32. Abbing V. Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol. 2014 [cited 2014 Feb 18];9(2):130-8. Available at: http://www.ingentaconnect.com/content/ben/ccp/2014/00000009/00000002/art00 005?crawler=true&mimetype=application/pdf

  33. Darin K, Klepser M, Klepser D, Klepser S, Reeves A. Pharmacist-provided rapid HIV testing in two community pharmacies. J Am Pharmacists Ass. 2015 [cited 2016 Feb 18];55(1):81-8. Available at: http://www.sciencedirect.com/science/article/pii/S1544319115300157

  34. Harmon M, Pogge E, Boomershine V. Evaluation of a pharmacist-led, 6-month weight loss program in obese patients. J Am Pharmacists Ass. 2014 [cited 2016 Feb 18];54(3):302-7. Available at: http://www.sciencedirect.com/science/article/pii/S1544319115301904

  35. Todd A, Moore H, Husband A, Bambra C, Kasim A, Sniehotta F, et al. Community pharmacy interventions for public health priorities: protocol for a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions. Syst rev. 2014 [cited 2016 Feb 18];55(1);3(1):1. Available at: http://systematicreviewsjournal.biomedcentral.com/articles/10.1186/2046-4053-3-93

  36. O'Connor S, Michaels N, Ferreri S. Expansion of pharmacogenomics into the community pharmacy: billing considerations. Pharmacogenomics. 2015 [cited 2016 Feb 18];16(3):175-80. Available at: http://www.futuremedicine.com/doi/full/10.2217/pgs.14.183

  37. O'Neal K, Crosby K. What is the Role of the Pharmacist in Obesity Management? Curr Obes Rep. 2014 [cited 2015 Nov 30];3:298-306. Available at: http://link.springer.com/article/10.1007%2Fs13679-014-0110-2#/page-1

  38. Tommelein E, Petrovic M, Somers A, Mehuys E, van der T, Boussery K. Older patients' prescriptions screening in the community pharmacy: development of the Ghent Older People's Prescriptions community Pharmacy Screening (GheOP3S) tool. J Public Health Adv Acc. 2015 [cited 2016 Feb 18]:1-13. Available at: https://jpubhealth.oxfordjournals.org/content/early/2015/07/13/pubmed.fdv090.ful l.pdf+html

  39. Erni P, von Overbeck J, Reich O, Ruggli M. Net Care, a new collaborative primary health care service based in Swiss community pharmacies. Res Social Administrative Phar. 2015 [cited 2016 Feb 18]. Available at: http://www.sciencedirect.com/science/article/pii/S1551741115001667

  40. Chiazor E, Evans M, van Woerden H, Oparah A. A systematic review of community pharmacists' interventions in reducing major risk factors for cardiovascular disease. Val Health Reg. 2015 [cited 2016 Feb 18];7:9-21. Available at: http://ac.els-cdn.com/S2212109915000102/1-s2.0-S2212109915000102- main.pdf?_tid=3bebe3c4-d65e-11e5-80fe- 00000aacb361&acdnat=1455813772_8f909ef1a2140dc5d5e75a225be92b19

  41. Nemire R, Ward C, Whalen K, Quinn J, Subramaniam V. Public health matters: the role of the pharmacist and the academy. Curr Pharmacy Teach Lear. 2010 [cited 2015 Dic 4];2:2-11. Available at: http://www.sciencedirect.com/.../pii/S1877129709000550

  42. Cheong L, Armour C, Bosnic S. Primary health care teams and the patient perspective: A social network analysis. Res Social Administrative Phar. 2013 [cited 2015 Dic 4];9:741-57. Available at: http://www.sciencedirect.com/.../pii/S1551741113000028

  43. Rosas A, Narciso V, Cuba M. Atributos de la Atención Primaria de Salud (A.P.S): Una visión desde la Medicina Familiar. Acta Med Per. 2013 [citado 5 Dic 2015];30(1):42-7. Disponible en: http://www.redalyc.org/articulo.oa?id=9662644600

  44. Goad J, Bach A. The role of community pharmacy-based vaccination in the USA: current practice and future directions. Integrat Pharmacy Res Prac. 2015;4:67-77.

  45. Patel H. Promoting self-care in the community: The evidence and why it is important. Insulin. 2016 [cited 2016 Feb 18];10:18. Available at: http://www.pharmaceutical-journal.com/learning/learning-article/promoting-selfcare- in-the-community-the-evidence-and-why-it-is-important/11137908.article

  46. Laliberté M, Perreault S, Damestoy N, Lalonde L. Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health. 2012 [cited 2015 Nov 29];12:192. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22420693

  47. Orueta R, Santos C, González E, Fagundo E, Lázaro G, Carmona, J et al. Medicalización de la vida. Rev Clin Med Fam. 2011 [citado 3 Dic 2014];4(2). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699- 695X2011000200011

  48. Agomo C, Ogunleye J. An investigation of strategies enhancing the public health role of community pharmacists: a review of knowledge and information. J Pharmaceutical Health Ser Res. 2014 [cited 2015 Dic 8];135-45. Available at: http://onlinelibrary.wiley.com/doi/10.1111/jphs.12056/abstract

  49. McMillan S, Wheeler A, Sav A, King M, Whitty J, Kendall E, et al. Community pharmacy in Australia: A health hub destination of the future. Res Social Administrative Phar. 2013 [cited 2015 Dic 2];9:863-75. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23218552

  50. Penm J, Li Y, Zhai S, Hu Y, Chaar B, Moles R. The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China's current healthcare reform. Health Pol Plann 2014[cited 2016 Feb 18];29(7):849-872. Available at: http://heapol.oxfordjournals.org/content/29/7/849

  51. Acheampong F, Panyin B, Asumeng G. Medication safety strategies in hospitals- A systematic review. The Internat J Risk Safety Med. 2014 [cited 2015 Nov 30];26(3):117-31. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25214157

  52. Monte S, Passafiume S, Kufel D, Comerford P, Trzewieczynski P, Andrus K, Brody P. Pharmacist home visits: A 1-year experience from a community pharmacy. J Am Pharmacists Ass. 2016 [cited 2016 Feb 18];56(1):67-72. Available at: http://www.sciencedirect.com/science/article/pii/S1544319115000035

  53. Bradley C. The future role of pharmacists in primary care. Br J Gen Prac. 2009 [cited 2015 Dic 4];59(569):891-2. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784524/pdf/bjgp59-891.pdf

  54. Edwards H, Webb R, Scheid D, Britton M, Armor B. A pharmacist visit improves diabetes standards in a patient-centered medical home (PCMH). Am J Med Quality. 2012 [cited 2016 Feb 18];27(6):529-34. Available at: http://ajm.sagepub.com/content/27/6/529.full.pdf+html

  55. Shulman R, McKenzie C, Landa J, Bourne R, Jones A, Borthwick M, Bates I. Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK). J Crit Care. 2015 [cited 2016 Feb 18];30(4):808-13. Available at: http://www.sciencedirect.com/science/article/pii/S0883944115001537

  56. Santschi V, Chiolero A, Burnand B, Colosimo A, Paradis G. Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors A Systematic Review and Meta-analysis of Randomized Trials. Arch Intern Med. 2011 [cited 2015 Dic 3];171(16):1441-53. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21911628

  57. Rubio M, Serrano A, Magdalena J, Fernández A, García J, March M, et al. Effectiveness of Pharmacist Care in the Improvement of Adherence to Antidepressants: A Systematic Review and Meta-Analysis. Ann Pharmacother. 2011 [cited 2015 Dic 8];45:39-48. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21205952

  58. Charrois T, Zolezzi M, Koshman S, Pearson G, Makowsky M, Durec T, et al. A Systematic Review of the Evidence for Pharmacist Care of Patients With Dyslipidemia. Pharmacotherapy. 2012 [cited 2015 Dic 4];32(3):222-33. Available at: http://ncbi.nlm.nih.gov/pubmed/22392455

  59. Fernández C, Calleja M, Manrique S, Pérez C, Duran E, Sanjurjo M. Impact of clinical pharmacist interventions in reducing paediatric prescribing errors. Arch Dis Child. 2012 [cited 2015 Dic 1];97(6):564-8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22362718

  60. Abdul M, Phillip D, Closs S, Briggs M. Effectiveness of Pharmacist-Led Medication Reviews in Improving Patient Outcomes in Chronic Pain: A Systematic Review Protocol. Can Pharmacists J. 2012 [cited 2015 Dic 3];145:264-6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24480911

  61. Rigby D. Medication in review: Pharmacists in GP practices: The benefit of interdisciplinary teams. Australian J Phar. 2014 [cited 2015 Dic 5];5(1124):61-3. Available at: http://www.search.informit.com.au/documentSummary;dn;res




2020     |     www.medigraphic.com